Novo Nordisk raises full-year guidance again as US sales of Wegovy, Ozempic fly - Reuters
reuters.comSubmitted by reuters8361 in business
Novo Nordisk <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> on Friday raised its outlook for its full-year sales and operating profit for the third time this year, reflecting strong demand for its weight-loss drug …